Login
$INM
$1.59 +$0.00 (0.0%) Close

$INM 4 SEC Filings

Filed On Filing
20 Oct 2026 Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other

Bought 1 shares ($1.32) · Bought 1,086 shares ($1.43K)

15 Oct 2026 Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other

Bought 564 shares ($750) · Bought 8,021 shares ($10.7K) · Bought 984 shares ($1.3K)

08 Oct 2026 Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other

Bought 5,601 shares ($7.44K) · Bought 3,046 shares ($4.05K) · Bought 2,256 shares ($3K)

05 Oct 2026 Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other

Bought 16,431 shares ($21.8K) · Bought 8,307 shares ($11K) · Bought 18,182 shares ($24.2K)

16 Sep 2026 Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other

Bought 28,505 shares ($36.9K) · Bought 54,256 shares ($70.4K) · Bought 8,340 shares ($10.8K)

17 Jul 2026 Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other

Bought 1,000 shares ($1.56K)

16 Jul 2026 Form 4: Vivo Opportunity, Llc, 10% owner and 3 others

Bought 5,375 shares ($8.33K) · Bought 15,150 shares ($23.5K) · Bought 21 shares ($32.6)

02 Jul 2026 Form 4: Vivo Opportunity, Llc, 10% owner and 3 others

Bought 600 shares ($924) · Bought 4,344 shares ($6.73K) · Bought 1,607 shares ($2.49K)

10 Jun 2026 Form 4: Vivo Opportunity, Llc, 10% owner and 3 others

Bought 56,210 shares ($87.7K) · Bought 34,000 shares ($57.5K) · Bought 17,796 shares ($27.9K) · 6 more

21 May 2026 Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other

Bought 468,551 shares ($722K)

19 Dec 2025 Form 4: Johnson Shane Aaron, Sr VP & General Manager

Granted 8,500 Employee Stock Option (Right to Buy)

19 Dec 2025 Form 4: Lemerond Nicole, Director

Granted 1,750 Employee Stock Option (Right to Buy)

19 Dec 2025 Form 4: Klompas Neil A, Director

Granted 1,750 Employee Stock Option (Right to Buy)

19 Dec 2025 Form 4: Jagpal Netta, Chief Financial Officer

Granted 18,000 Employee Stock Option (Right to Buy)

19 Dec 2025 Form 4: Woudenberg Michael, Chief Operating Officer

Granted 18,000 Employee Stock Option (Right to Buy)

19 Dec 2025 Form 4: Bathery John Steven, Director

Granted 1,750 Employee Stock Option (Right to Buy)

19 Dec 2025 Form 4: Hsu Eric C, Sr. VP, Pre-Clinical Res/Dev

Granted 13,000 Employee Stock Option (Right to Buy)

19 Dec 2025 Form 4: Adams Eric A, Director

Granted 35,000 Employee Stock Option (Right to Buy)

19 Dec 2025 Form 4: Hull Andrew, Director

Granted 1,750 Employee Stock Option (Right to Buy)

17 Dec 2025 Form 4: Hull Andrew, Director

Disposed of 14 Employee Stock Option (Expiration) (Long Position Expiration)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support